logo

ONC

Beone Medicines·NASDAQ
--
--(--)
--
--(--)

ONC fundamentals

Beone Medicines (ONC) released its earnings on Feb 26, 2026: revenue was 1.50B (YoY +32.84%), beat estimates; EPS was 0.06 (YoY +104.20%), missed estimates.
Revenue / YoY
1.50B
+32.84%
EPS / YoY
0.06
+104.20%
Report date
Feb 26, 2026
Earnings Call
8:00 AM on Feb 26, 2026
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

ONC has released its 2025 Q4 earnings report, with revenue of 1.50B, reflecting a YoY change of 32.84%, and net profit of 66.50M, showing a YoY change of 143.79%. The Sankey diagram below clearly presents ONC's revenue sources and cost distribution.

Key Indicators

Beone Medicines (ONC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Beone Medicines (ONC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Beone Medicines (ONC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Beone Medicines (ONC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Beone Medicines (ONC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Beone Medicines (ONC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield